Uterine serous carcinoma (USC) is a rare but aggressive subtype of endometrial carcinoma. Largescale comprehensive efforts have resulted in an improved molecular understanding of its pathogenesis, and the p53 pathway has been proposed as a key player and is potentially targetable. | High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma